{"hands_on_practices": [{"introduction": "Clinical medicine often involves reasoning backward from a patient's symptoms to a specific molecular cause. This practice problem challenges you to act as a clinical detective, using foundational principles of adrenal steroidogenesis and the hypothalamic-pituitary-adrenal (HPA) axis to diagnose a classic endocrine disorder [@problem_id:4945168]. By working through the logic, you'll gain a deep appreciation for how a single enzyme defect can cause a cascade of systemic effects.", "problem": "A neonate within the first week of life presents with poor feeding, vomiting, dehydration, and ambiguous genitalia in a genotypic female. There is no known maternal medication exposure. A congenital enzymatic block in adrenal steroidogenesis is suspected. Using only the following foundational principles as your starting base, reason to a prediction of the predominant steroid accumulation pattern, the electrolyte and blood pressure consequences, and the mechanism linking the enzymatic block to elevated adrenocorticotropic hormone (ACTH) and adrenal hyperplasia.\n\nFoundational principles:\n- The adrenal cortex synthesizes mineralocorticoids in the zona glomerulosa, glucocorticoids in the zona fasciculata, and androgens in the zona reticularis.\n- The hypothalamic-pituitary-adrenal (HPA) axis operates by corticotropin-releasing hormone (CRH) from the hypothalamus stimulating ACTH release from the anterior pituitary; cortisol exerts negative feedback on both CRH and ACTH.\n- Aldosterone promotes renal collecting duct and distal tubule reabsorption of sodium and water and secretion of potassium via the mineralocorticoid receptor, affecting effective circulating volume, plasma sodium, and plasma potassium.\n- In the glucocorticoid and mineralocorticoid pathways, $21$-hydroxylase catalyzes the conversion of progesterone to $11$-deoxycorticosterone and $17$-hydroxyprogesterone to $11$-deoxycortisol.\n\nWhich option best integrates the predicted steroid accumulation, electrolyte consequences, and the mechanistic link to elevated ACTH and adrenal hyperplasia in classic $21$-hydroxylase deficiency?\n\nA. Accumulation of $17$-hydroxyprogesterone and progesterone with decreased cortisol and aldosterone, causing hyponatremia, hyperkalemia, and hypotension; elevated ACTH due to loss of cortisol negative feedback drives bilateral adrenal hyperplasia via chronic trophic stimulation.\n\nB. Accumulation of $11$-deoxycorticosterone producing hypertension and hypokalemia; reduced ACTH due to mineralocorticoid excess suppressing the hypothalamic-pituitary axis; resultant adrenal cortical atrophy.\n\nC. Diversion of precursors into aldosterone synthesis, leading to hypernatremia and metabolic alkalosis with normal blood pressure; elevated ACTH primarily due to nonspecific stress.\n\nD. Normal aldosterone synthesis because $21$-hydroxylase is confined to the zona fasciculata; therefore, electrolytes remain normal; ACTH rises because excess androgens directly stimulate the pituitary, and adrenal size is unchanged.", "solution": "The problem statement is subjected to validation before proceeding to a solution.\n\n### Step 1: Extract Givens\n- **Clinical Presentation:** A neonate in the first week of life presents with poor feeding, vomiting, dehydration, and ambiguous genitalia. The neonate is a genotypic female. There is no known maternal medication exposure.\n- **Hypothesis:** A congenital enzymatic block in adrenal steroidogenesis.\n- **Foundational Principle 1:** The adrenal cortex is zoned for synthesis: zona glomerulosa (mineralocorticoids), zona fasciculata (glucocorticoids), and zona reticularis (androgens).\n- **Foundational Principle 2:** The hypothalamic-pituitary-adrenal (HPA) axis functions via corticotropin-releasing hormone ($CRH$) stimulating adrenocorticotropic hormone ($ACTH$), with cortisol providing negative feedback on both $CRH$ and $ACTH$.\n- **Foundational Principle 3:** Aldosterone acts on the kidney to promote reabsorption of sodium ($Na$) and water, and secretion of potassium ($K$), thereby regulating effective circulating volume and plasma electrolyte concentrations.\n- **Foundational Principle 4:** The enzyme $21$-hydroxylase catalyzes the conversion of progesterone to $11$-deoxycorticosterone and $17$-hydroxyprogesterone to $11$-deoxycortisol.\n- **Question:** The task is to predict the steroid accumulation pattern, electrolyte and blood pressure consequences, and the mechanism for elevated $ACTH$ and adrenal hyperplasia in classic $21$-hydroxylase deficiency, based only on the provided principles.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed for validity.\n- **Scientifically Grounded:** The problem is firmly based on established principles of human endocrine physiology and pathophysiology. The provided principles are accurate summaries of adrenal steroidogenesis, HPA axis regulation, and aldosterone action. The clinical vignette is a classic presentation of congenital adrenal hyperplasia (CAH).\n- **Well-Posed:** The problem provides sufficient information within its foundational principles to allow for a unique, logical deduction of the consequences of the specified enzyme block.\n- **Objective:** The language is clinical and scientific, devoid of subjective or biased statements.\n\nThe problem does not exhibit any flaws such as scientific unsoundness, incompleteness, or ambiguity. All terms are standard in endocrinology and medicine.\n\n### Step 3: Verdict and Action\nThe problem statement is **valid**. A solution will be derived based on the provided principles.\n\n### Derivation from Foundational Principles\n\n1.  **Identify the Enzymatic Block and its Direct Consequences:** The problem states to consider a deficiency in the $21$-hydroxylase enzyme. According to Foundational Principle 4, this enzyme is required for two steps:\n    - Progesterone $\\xrightarrow{21-hydroxylase}$ $11$-deoxycorticosterone (a precursor to aldosterone in the mineralocorticoid pathway).\n    - $17$-hydroxyprogesterone $\\xrightarrow{21-hydroxylase}$ $11$-deoxycortisol (a precursor to cortisol in the glucocorticoid pathway).\n    A deficiency in $21$-hydroxylase will block both of these reactions. Consequently, the synthesis of hormones downstream from these steps will be severely impaired. This leads to a deficiency of both **aldosterone** and **cortisol**.\n\n2.  **Predict Steroid Accumulation:** Due to the enzymatic block, the substrates immediately upstream of the block will accumulate. These substrates are **progesterone** and, most notably, **$17$-hydroxyprogesterone**.\n\n3.  **Predict Pathway Shunting:** According to Foundational Principle 1, the adrenal cortex has a third pathway for steroid synthesis: the androgen pathway in the zona reticularis. With the glucocorticoid and mineralocorticoid pathways blocked, the accumulating precursors (particularly $17$-hydroxyprogesterone) are shunted into the androgen synthesis pathway. This results in an **overproduction of adrenal androgens**. In a genotypic female, this prenatal androgen excess leads to virilization of the external genitalia, explaining the presentation of **ambiguous genitalia**.\n\n4.  **Analyze Consequences of Aldosterone Deficiency:** According to Foundational Principle 3, aldosterone promotes renal $Na$ and water reabsorption and $K$ secretion. A deficiency of aldosterone will therefore cause:\n    - Renal salt wasting (loss of $Na$). This leads to **hyponatremia** (low plasma $Na$).\n    - Impaired renal $K$ secretion. This leads to **hyperkalemia** (high plasma $K$).\n    - Loss of $Na$ and water leads to a decrease in effective circulating volume, resulting in **hypotension** and **dehydration**. This directly explains the neonate's clinical signs of poor feeding, vomiting, and dehydration (so-called \"salt-wasting crisis\").\n\n5.  **Analyze Consequences of Cortisol Deficiency and HPA Axis Response:** According to Foundational Principle 2, cortisol exerts negative feedback on the HPA axis. The profound deficiency of cortisol resulting from the $21$-hydroxylase block removes this negative feedback. The hypothalamus and anterior pituitary respond by dramatically increasing the secretion of $CRH$ and, subsequently, **$ACTH$**.\n\n6.  **Analyze Consequences of Elevated ACTH:** $ACTH$ is the primary trophic (growth-stimulating) factor for the adrenal cortex, particularly the zona fasciculata and reticularis. The chronic and severe elevation of $ACTH$ perpetually stimulates the adrenal glands, leading to their compensatory enlargement, a condition known as **bilateral adrenal hyperplasia**. This stimulation also drives the overproduction of precursors and their shunting into the androgen pathway.\n\n### Summary of Predictions\n- **Steroid Profile:** Deficient cortisol and aldosterone. Accumulated progesterone and $17$-hydroxyprogesterone. Excess adrenal androgens.\n- **Electrolyte/Hemodynamic Profile:** Hyponatremia, hyperkalemia, hypotension, volume depletion.\n- **HPA Axis/Adrenal Morphology:** Elevated $ACTH$ due to loss of cortisol negative feedback, leading to bilateral adrenal hyperplasia.\n\n### Option-by-Option Analysis\n\n**A. Accumulation of $17$-hydroxyprogesterone and progesterone with decreased cortisol and aldosterone, causing hyponatremia, hyperkalemia, and hypotension; elevated ACTH due to loss of cortisol negative feedback drives bilateral adrenal hyperplasia via chronic trophic stimulation.**\n- This option correctly identifies the accumulation of $17$-hydroxyprogesterone and progesterone and the deficiency of cortisol and aldosterone.\n- It correctly links aldosterone deficiency to hyponatremia, hyperkalemia, and hypotension.\n- It correctly describes the mechanism of $ACTH$ elevation (loss of cortisol feedback) and its consequence (bilateral adrenal hyperplasia).\n- This statement fully aligns with the derivation from the foundational principles.\n- **Verdict: Correct.**\n\n**B. Accumulation of $11$-deoxycorticosterone producing hypertension and hypokalemia; reduced ACTH due to mineralocorticoid excess suppressing the hypothalamic-pituitary axis; resultant adrenal cortical atrophy.**\n- This is incorrect. The block is at $21$-hydroxylase, which *prevents* the synthesis of $11$-deoxycorticosterone. Therefore, $11$-deoxycorticosterone levels would be low, not high. The symptoms described (hypertension, hypokalemia) are characteristic of mineralocorticoid excess, which is the opposite of the situation in classic $21$-hydroxylase deficiency. Furthermore, $ACTH$ is elevated, not reduced, and hyperplasia, not atrophy, occurs. This pathophysiology is more descriptive of $11\\beta$-hydroxylase deficiency.\n- **Verdict: Incorrect.**\n\n**C. Diversion of precursors into aldosterone synthesis, leading to hypernatremia and metabolic alkalosis with normal blood pressure; elevated ACTH primarily due to nonspecific stress.**\n- This is incorrect. The enzymatic block *prevents* aldosterone synthesis; it does not divert precursors towards it. The electrolyte abnormalities described (hypernatremia, metabolic alkalosis) are signs of mineralocorticoid excess, not deficiency. While stress is present, the primary driver for the sustained high $ACTH$ level is the specific failure of the negative feedback loop.\n- **Verdict: Incorrect.**\n\n**D. Normal aldosterone synthesis because $21$-hydroxylase is confined to the zona fasciculata; therefore, electrolytes remain normal; ACTH rises because excess androgens directly stimulate the pituitary, and adrenal size is unchanged.**\n- This is incorrect on multiple points. First, the premise that $21$-hydroxylase is confined to the zona fasciculata is false; it is essential for both mineralocorticoid and glucocorticoid synthesis (Principle 4) and is thus present in both the zona glomerulosa and fasciculata. Aldosterone synthesis is therefore not normal. Second, as a result, electrolytes are profoundly abnormal. Third, the primary cause of elevated a $ACTH$ is lack of cortisol feedback, not androgen stimulation. Fourth, chronic $ACTH$ stimulation causes hyperplasia, so the adrenal size would be increased, not unchanged.\n- **Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "4945168"}, {"introduction": "Physiological systems maintain homeostasis through finely tuned control loops, and modeling these responses quantitatively is a key skill. This exercise provides a hands-on look at one such mechanism: the regulation of aldosterone secretion by extracellular potassium levels [@problem_id:4945209]. By applying a linear approximation, you will practice a powerful technique used to model and predict how a system responds to a given stimulus.", "problem": "Aldosterone is secreted by zona glomerulosa cells of the adrenal cortex and increases renal sodium retention. A well-tested physiological observation is that extracellular potassium concentration modulates aldosterone secretion: an increase in extracellular potassium depolarizes zona glomerulosa cells, raising aldosterone output. Near a given baseline, this stimulus-secretion dependence can be approximated locally as linear. Assume the following conditions:\n- Baseline extracellular potassium concentration is $[\\mathrm{K}^{+}]_{0} = 4.0\\,\\mathrm{mM}$.\n- Extracellular potassium concentration rises to $[\\mathrm{K}^{+}]_{1} = 5.5\\,\\mathrm{mM}$.\n- The local slope (sensitivity) of the aldosterone secretion rate with respect to extracellular potassium at baseline is $s = \\dfrac{\\mathrm{d}A}{\\mathrm{d}[\\mathrm{K}^{+}]} = 25\\,\\mathrm{ng}\\,\\mathrm{min}^{-1}\\,\\mathrm{mM}^{-1}$.\n- The baseline aldosterone secretion rate is $A_{0} = 100\\,\\mathrm{ng}\\,\\mathrm{min}^{-1}$.\nAssume other regulators (such as angiotensin II and adrenocorticotropic hormone) remain constant during the change in $[\\mathrm{K}^{+}]$, and that the linear approximation is valid over this range. Using only these well-tested facts and the local linear approximation, compute the fractional change in aldosterone secretion, defined as $\\dfrac{A_{1} - A_{0}}{A_{0}}$, where $A_{1}$ is the secretion rate after the rise in $[\\mathrm{K}^{+}]$. Express your final answer as a pure decimal number with no units, and round your answer to three significant figures.", "solution": "The problem asks for the fractional change in aldosterone secretion rate given a change in extracellular potassium concentration. The core of the problem lies in applying a local linear approximation, a standard method in calculus and modeling to estimate the change in a function's output for a small change in its input.\n\nLet $A$ be the aldosterone secretion rate and $[\\mathrm{K}^{+}]$ be the extracellular potassium concentration. The relationship is given by the function $A([\\mathrm{K}^{+}])$. We are given the baseline conditions, which we denote with a subscript $0$:\n-   Baseline potassium concentration: $[\\mathrm{K}^{+}]_{0} = 4.0\\,\\mathrm{mM}$\n-   Baseline aldosterone secretion rate: $A_{0} = A([\\mathrm{K}^{+}]_{0}) = 100\\,\\mathrm{ng}\\,\\mathrm{min}^{-1}$\n\nWe are also given the sensitivity of aldosterone secretion to potassium concentration at this baseline, which is the derivative of the function $A$ with respect to $[\\mathrm{K}^{+}]$ evaluated at the baseline point:\n$$s = \\frac{\\mathrm{d}A}{\\mathrm{d}[\\mathrm{K}^{+}]} \\bigg|_{[\\mathrm{K}^{+}]_{0}} = 25\\,\\mathrm{ng}\\,\\mathrm{min}^{-1}\\,\\mathrm{mM}^{-1}$$\nThe extracellular potassium concentration increases to a new value, which we denote with a subscript $1$:\n$$[\\mathrm{K}^{+}]_{1} = 5.5\\,\\mathrm{mM}$$\nThe problem states that the linear approximation is valid over this range. This means we can approximate the change in aldosterone secretion, $\\Delta A = A_{1} - A_{0}$, using the first-order Taylor expansion (or the definition of the derivative for a finite, small change):\n$$\\Delta A \\approx \\frac{\\mathrm{d}A}{\\mathrm{d}[\\mathrm{K}^{+}]} \\bigg|_{[\\mathrm{K}^{+}]_{0}} \\times \\Delta[\\mathrm{K}^{+}]$$\nwhere $A_{1}$ is the new secretion rate at $[\\mathrm{K}^{+}]_{1}$, and $\\Delta[\\mathrm{K}^{+}] = [\\mathrm{K}^{+}]_{1} - [\\mathrm{K}^{+}]_{0}$.\n\nFirst, we calculate the change in potassium concentration:\n$$\\Delta[\\mathrm{K}^{+}] = [\\mathrm{K}^{+}]_{1} - [\\mathrm{K}^{+}]_{0} = 5.5\\,\\mathrm{mM} - 4.0\\,\\mathrm{mM} = 1.5\\,\\mathrm{mM}$$\nNext, we use the linear approximation to estimate the absolute change in aldosterone secretion rate, $\\Delta A$:\n$$\\Delta A \\approx s \\times \\Delta[\\mathrm{K}^{+}] = (25\\,\\mathrm{ng}\\,\\mathrm{min}^{-1}\\,\\mathrm{mM}^{-1}) \\times (1.5\\,\\mathrm{mM})$$\n$$\\Delta A \\approx 37.5\\,\\mathrm{ng}\\,\\mathrm{min}^{-1}$$\nThe quantity we need to compute is the fractional change in aldosterone secretion, which is defined as $\\frac{A_{1} - A_{0}}{A_{0}}$, or simply $\\frac{\\Delta A}{A_{0}}$.\nUsing the values for $\\Delta A$ we just calculated and the given baseline secretion rate $A_{0}$:\n$$\\text{Fractional change} = \\frac{\\Delta A}{A_0} \\approx \\frac{37.5\\,\\mathrm{ng}\\,\\mathrm{min}^{-1}}{100\\,\\mathrm{ng}\\,\\mathrm{min}^{-1}}$$\nThe units cancel, resulting in a dimensionless quantity, as expected for a fractional change.\n$$\\text{Fractional change} \\approx 0.375$$\nThe problem requires the answer to be expressed as a pure decimal number rounded to three significant figures. The calculated value, $0.375$, has exactly three significant figures (the digits $3$, $7$, and $5$), so no further rounding is necessary.", "answer": "$$\\boxed{0.375}$$", "id": "4945209"}, {"introduction": "The biological activity of a hormone depends not on its total concentration, but on its unbound, or \"free,\" fraction, a critical concept in endocrinology. This problem delves into the chemical equilibrium that governs hormone binding to plasma proteins like corticosteroid-binding globulin (CBG) and albumin [@problem_id:4945224]. You will derive these relationships from the law of mass action and calculate how changes in binding protein levels can significantly alter the amount of active hormone available to tissues.", "problem": "A patient in the early morning has a measured total plasma cortisol concentration, denoted $C_T$, in the physiological range. Cortisol binds with high affinity to corticosteroid-binding globulin (CBG) and with lower affinity to albumin. Assume single-site, $1{:}1$ binding for cortisol to each protein, no cooperativity, and negligible binding to other partners. Use only the law of mass action and the definition of the dissociation constant ($K_d$) as your fundamental starting point to derive the relationships you need.\n\nData (all concentrations in mol per liter):\n- Baseline total cortisol: $C_T = 4.00 \\times 10^{-7}$.\n- Baseline total CBG: $[\\mathrm{CBG}]_T = 6.00 \\times 10^{-7}$ with $K_{d,\\mathrm{CBG}} = 1.00 \\times 10^{-8}$.\n- Total albumin: $[\\mathrm{Alb}]_T = 6.00 \\times 10^{-4}$ with $K_{d,\\mathrm{Alb}} = 1.00 \\times 10^{-4}$.\n\nScenario: An intervention that mimics an estrogen effect doubles CBG production, so $[\\mathrm{CBG}]_T$ becomes $1.20 \\times 10^{-6}$, while $C_T$, $[\\mathrm{Alb}]_T$, $K_{d,\\mathrm{CBG}}$, and $K_{d,\\mathrm{Alb}}$ are unchanged.\n\nTask:\n- Starting from the law of mass action and the definition of $K_d$, derive the mass-balance relation for cortisol among its free, CBG-bound, and albumin-bound pools.\n- Compute the baseline free cortisol concentration $[\\mathrm{C}]_f$ and the baseline free cortisol fraction $[\\mathrm{C}]_f/C_T$.\n- Compute the new free cortisol concentration after doubling $[\\mathrm{CBG}]_T$.\n- Report as your final answer only the fold-change in free cortisol concentration, defined as $\\text{fold-change} = [\\mathrm{C}]_{f,\\text{after}}/[\\mathrm{C}]_{f,\\text{before}}$, as a pure number (unitless), rounded to four significant figures. Do not include units in your final answer.", "solution": "The problem is valid as it is scientifically grounded in the principles of ligand-receptor binding kinetics, is well-posed with sufficient and consistent data, and is expressed in objective, formal language. We can proceed with the solution.\n\nThe problem requires us to analyze the equilibrium distribution of cortisol (C) among its free state and its states bound to corticosteroid-binding globulin (CBG) and albumin (Alb). The binding interactions are described by the following reversible reactions:\n$$ \\mathrm{C} + \\mathrm{CBG} \\rightleftharpoons \\mathrm{C-CBG} $$\n$$ \\mathrm{C} + \\mathrm{Alb} \\rightleftharpoons \\mathrm{C-Alb} $$\n\nFollowing the law of mass action, the dissociation constants ($K_d$) for these reactions are defined as:\n$$ K_{d,\\mathrm{CBG}} = \\frac{[\\mathrm{C}]_f [\\mathrm{CBG}]_f}{[\\mathrm{C-CBG}]} $$\n$$ K_{d,\\mathrm{Alb}} = \\frac{[\\mathrm{C}]_f [\\mathrm{Alb}]_f}{[\\mathrm{C-Alb}]} $$\nwhere $[\\mathrm{C}]_f$, $[\\mathrm{CBG}]_f$, and $[\\mathrm{Alb}]_f$ are the concentrations of free cortisol, free CBG, and free albumin, respectively, and $[\\mathrm{C-CBG}]$ and $[\\mathrm{C-Alb}]$ are the concentrations of the cortisol-protein complexes.\n\nThe total concentrations of each species are given by the mass-balance equations:\n1. Total Cortisol: $C_T = [\\mathrm{C}]_f + [\\mathrm{C-CBG}] + [\\mathrm{C-Alb}]$\n2. Total CBG: $[\\mathrm{CBG}]_T = [\\mathrm{CBG}]_f + [\\mathrm{C-CBG}]$\n3. Total Albumin: $[\\mathrm{Alb}]_T = [\\mathrm{Alb}]_f + [\\mathrm{C-Alb}]$\n\nTo derive the requested mass-balance relation for cortisol in terms of its free concentration, we first express the concentrations of the bound complexes as a function of $[\\mathrm{C}]_f$. From the mass-balance equation for CBG, we have $[\\mathrm{CBG}]_f = [\\mathrm{CBG}]_T - [\\mathrm{C-CBG}]$. Substituting this into the $K_{d,\\mathrm{CBG}}$ definition:\n$$ K_{d,\\mathrm{CBG}} = \\frac{[\\mathrm{C}]_f ([\\mathrm{CBG}]_T - [\\mathrm{C-CBG}])}{[\\mathrm{C-CBG}]} $$\nRearranging to solve for $[\\mathrm{C-CBG}]$:\n$$ K_{d,\\mathrm{CBG}}[\\mathrm{C-CBG}] = [\\mathrm{C}]_f [\\mathrm{CBG}]_T - [\\mathrm{C}]_f [\\mathrm{C-CBG}] $$\n$$ [\\mathrm{C-CBG}](K_{d,\\mathrm{CBG}} + [\\mathrm{C}]_f) = [\\mathrm{C}]_f [\\mathrm{CBG}]_T $$\n$$ [\\mathrm{C-CBG}] = \\frac{[\\mathrm{CBG}]_T [\\mathrm{C}]_f}{K_{d,\\mathrm{CBG}} + [\\mathrm{C}]_f} $$\nBy an identical derivation for albumin:\n$$ [\\mathrm{C-Alb}] = \\frac{[\\mathrm{Alb}]_T [\\mathrm{C}]_f}{K_{d,\\mathrm{Alb}} + [\\mathrm{C}]_f} $$\nSubstituting these expressions into the mass-balance equation for total cortisol fulfills the first task:\n$$ C_T = [\\mathrm{C}]_f + \\frac{[\\mathrm{CBG}]_T [\\mathrm{C}]_f}{K_{d,\\mathrm{CBG}} + [\\mathrm{C}]_f} + \\frac{[\\mathrm{Alb}]_T [\\mathrm{C}]_f}{K_{d,\\mathrm{Alb}} + [\\mathrm{C}]_f} $$\nThis equation relates the total cortisol concentration to its free concentration and the system parameters.\n\nNext, we compute the baseline free cortisol concentration, $[\\mathrm{C}]_{f,\\text{before}}$. Let $x = [\\mathrm{C}]_{f,\\text{before}}$. The given baseline values are:\n$C_T = 4.00 \\times 10^{-7}$\n$[\\mathrm{CBG}]_T = 6.00 \\times 10^{-7}$\n$K_{d,\\mathrm{CBG}} = 1.00 \\times 10^{-8}$\n$[\\mathrm{Alb}]_T = 6.00 \\times 10^{-4}$\n$K_{d,\\mathrm{Alb}} = 1.00 \\times 10^{-4}$\n\nThe equation to solve for $x$ is:\n$$ 4.00 \\times 10^{-7} = x + \\frac{(6.00 \\times 10^{-7}) x}{1.00 \\times 10^{-8} + x} + \\frac{(6.00 \\times 10^{-4}) x}{1.00 \\times 10^{-4} + x} $$\nWe observe that the free cortisol concentration $x$ is expected to be small, likely on the order of $K_{d,\\mathrm{CBG}}$ ($10^{-8}$ M), which is much smaller than $K_{d,\\mathrm{Alb}}$ ($10^{-4}$ M). Thus, we can make the valid approximation $x \\ll K_{d,\\mathrm{Alb}}$, which simplifies the albumin-binding term:\n$$ \\frac{(6.00 \\times 10^{-4}) x}{1.00 \\times 10^{-4} + x} \\approx \\frac{(6.00 \\times 10^{-4}) x}{1.00 \\times 10^{-4}} = 6.00 x $$\nThe equation becomes:\n$$ 4.00 \\times 10^{-7} = x + \\frac{(6.00 \\times 10^{-7}) x}{1.00 \\times 10^{-8} + x} + 6.00 x $$\n$$ 4.00 \\times 10^{-7} = 7.00 x + \\frac{(6.00 \\times 10^{-7}) x}{1.00 \\times 10^{-8} + x} $$\nMultiplying by $(1.00 \\times 10^{-8} + x)$ to clear the denominator yields a quadratic equation:\n$$ (4.00 \\times 10^{-7})(1.00 \\times 10^{-8} + x) = 7.00 x (1.00 \\times 10^{-8} + x) + (6.00 \\times 10^{-7}) x $$\n$$ 4.00 \\times 10^{-15} + (4.00 \\times 10^{-7}) x = (7.00 \\times 10^{-8}) x + 7.00 x^2 + (6.00 \\times 10^{-7}) x $$\n$$ 7.00 x^2 + (6.70 \\times 10^{-7}) x - (4.00 \\times 10^{-7}) x - 4.00 \\times 10^{-15} = 0 $$\n$$ 7.00 x^2 + (2.70 \\times 10^{-7}) x - 4.00 \\times 10^{-15} = 0 $$\nSolving for $x$ using the quadratic formula $x = \\frac{-b \\pm \\sqrt{b^2-4ac}}{2a}$, with $a=7.00$, $b=2.70 \\times 10^{-7}$, and $c=-4.00 \\times 10^{-15}$:\n$$ x = \\frac{-(2.70 \\times 10^{-7}) + \\sqrt{(2.70 \\times 10^{-7})^2 - 4(7.00)(-4.00 \\times 10^{-15})}}{2(7.00)} $$\n$$ x = \\frac{-2.70 \\times 10^{-7} + \\sqrt{7.29 \\times 10^{-14} + 11.2 \\times 10^{-14}}}{14} $$\n$$ x = \\frac{-2.70 \\times 10^{-7} + \\sqrt{18.49 \\times 10^{-14}}}{14} = \\frac{-2.70 \\times 10^{-7} + 4.30 \\times 10^{-7}}{14} $$\n$$ x = \\frac{1.60 \\times 10^{-7}}{14} \\approx 1.1429 \\times 10^{-8} $$\nSo, $[\\mathrm{C}]_{f,\\text{before}} = \\frac{1.60}{14} \\times 10^{-7} \\text{ M}$. The baseline free cortisol fraction is $\\frac{[\\mathrm{C}]_{f,\\text{before}}}{C_T} = \\frac{1.1429 \\times 10^{-8}}{4.00 \\times 10^{-7}} \\approx 0.0286$, or $2.86\\%$.\n\nNow, we compute the new free cortisol concentration, $[\\mathrm{C}]_{f,\\text{after}}$, after the intervention. Let $x' = [\\mathrm{C}]_{f,\\text{after}}$. The new total CBG concentration is $[\\mathrm{CBG}']_T = 1.20 \\times 10^{-6}$ M. All other parameters remain the same. The governing equation, using the same valid approximation, is:\n$$ 4.00 \\times 10^{-7} = 7.00 x' + \\frac{(1.20 \\times 10^{-6}) x'}{1.00 \\times 10^{-8} + x'} $$\n$$ (4.00 \\times 10^{-7})(1.00 \\times 10^{-8} + x') = 7.00 x' (1.00 \\times 10^{-8} + x') + (1.20 \\times 10^{-6}) x' $$\n$$ 4.00 \\times 10^{-15} + (4.00 \\times 10^{-7}) x' = (7.00 \\times 10^{-8}) x' + 7.00 (x')^2 + (1.20 \\times 10^{-6}) x' $$\n$$ 7.00 (x')^2 + (1.27 \\times 10^{-6}) x' - (4.00 \\times 10^{-7}) x' - 4.00 \\times 10^{-15} = 0 $$\n$$ 7.00 (x')^2 + (8.70 \\times 10^{-7}) x' - 4.00 \\times 10^{-15} = 0 $$\nSolving for $x'$ with $a=7.00$, $b=8.70 \\times 10^{-7}$, and $c=-4.00 \\times 10^{-15}$:\n$$ x' = \\frac{-(8.70 \\times 10^{-7}) + \\sqrt{(8.70 \\times 10^{-7})^2 - 4(7.00)(-4.00 \\times 10^{-15})}}{2(7.00)} $$\n$$ x' = \\frac{-8.70 \\times 10^{-7} + \\sqrt{7.569 \\times 10^{-13} + 1.12 \\times 10^{-13}}}{14} $$\n$$ x' = \\frac{-8.70 \\times 10^{-7} + \\sqrt{8.689 \\times 10^{-13}}}{14} = \\frac{-8.70 \\times 10^{-7} + 9.32148 \\times 10^{-7}}{14} $$\n$$ x' = \\frac{0.62148 \\times 10^{-7}}{14} \\approx 4.4391 \\times 10^{-9} $$\nSo, $[\\mathrm{C}]_{f,\\text{after}} = \\frac{0.62148}{14} \\times 10^{-7} \\text{ M}$.\n\nFinally, we compute the fold-change in free cortisol concentration:\n$$ \\text{fold-change} = \\frac{[\\mathrm{C}]_{f,\\text{after}}}{[\\mathrm{C}]_{f,\\text{before}}} = \\frac{\\frac{0.62148 \\times 10^{-7}}{14}}{\\frac{1.60 \\times 10^{-7}}{14}} = \\frac{0.62148}{1.60} $$\n$$ \\text{fold-change} \\approx 0.388425 $$\nRounding to four significant figures, the fold-change is $0.3884$.", "answer": "$$\n\\boxed{0.3884}\n$$", "id": "4945224"}]}